Canoe Financial LP Acquires 194,555 Shares of CVS Health Corporation $CVS

Canoe Financial LP lifted its holdings in shares of CVS Health Corporation (NYSE:CVS) by 11.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,899,163 shares of the pharmacy operator’s stock after acquiring an additional 194,555 shares during the quarter. CVS Health makes up about 2.0% of Canoe Financial LP’s portfolio, making the stock its 16th biggest holding. Canoe Financial LP’s holdings in CVS Health were worth $150,718,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the business. Capital World Investors lifted its holdings in CVS Health by 2.1% during the 3rd quarter. Capital World Investors now owns 68,382,158 shares of the pharmacy operator’s stock valued at $5,155,380,000 after purchasing an additional 1,419,575 shares during the last quarter. State Street Corp raised its position in shares of CVS Health by 0.3% in the third quarter. State Street Corp now owns 58,938,286 shares of the pharmacy operator’s stock valued at $4,443,357,000 after purchasing an additional 149,701 shares during the period. Capital International Investors raised its position in shares of CVS Health by 1.1% in the third quarter. Capital International Investors now owns 26,692,203 shares of the pharmacy operator’s stock valued at $2,012,347,000 after purchasing an additional 302,499 shares during the period. Invesco Ltd. lifted its stake in shares of CVS Health by 3.2% during the 3rd quarter. Invesco Ltd. now owns 24,293,058 shares of the pharmacy operator’s stock worth $1,831,454,000 after buying an additional 760,579 shares during the last quarter. Finally, Capital Research Global Investors boosted its holdings in shares of CVS Health by 24.5% during the 3rd quarter. Capital Research Global Investors now owns 11,469,250 shares of the pharmacy operator’s stock worth $864,667,000 after buying an additional 2,253,531 shares during the period. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Down 1.5%

Shares of CVS opened at $70.08 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. CVS Health Corporation has a 12 month low of $58.35 and a 12 month high of $85.15. The firm’s 50 day moving average is $76.62 and its 200-day moving average is $77.77. The stock has a market capitalization of $89.16 billion, a PE ratio of 50.79, a P/E/G ratio of 0.73 and a beta of 0.49.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The business had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. During the same quarter in the prior year, the business posted $1.19 earnings per share. The firm’s quarterly revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Equities research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, May 4th. Stockholders of record on Thursday, April 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.8%. The ex-dividend date of this dividend is Thursday, April 23rd. CVS Health’s dividend payout ratio is 192.75%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on CVS. Bank of America lowered their price target on shares of CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a report on Tuesday, January 27th. Leerink Partners reaffirmed an “outperform” rating and issued a $98.00 target price on shares of CVS Health in a research report on Thursday, March 5th. Mizuho lifted their price target on CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, December 10th. Robert W. Baird boosted their price target on CVS Health from $82.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of CVS Health in a research report on Wednesday, December 10th. Twenty analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and a consensus price target of $95.05.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.